Vitamin D and calcium co-therapy mitigates pre-established cadmium nephropathy by regulating renal calcium homeostatic molecules and improving anti-oxidative and anti-inflammatory activities in rat
Cadmium (Cd) is a major environmental pollutant and chronic toxicity could induce nephropathy by increasing renal oxidative stress and inflammation. Although vitamin D (VD) and calcium (Ca) prophylactic treatments attenuated Cd-induced cell injury, none of the prior studies measure their renoprotect...
Gespeichert in:
| Veröffentlicht in: | Journal of trace elements in medicine and biology 2023-09, Vol.79, p.127221-127221, Article 127221 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 127221 |
|---|---|
| container_issue | |
| container_start_page | 127221 |
| container_title | Journal of trace elements in medicine and biology |
| container_volume | 79 |
| creator | Obaid, Ahmad A. Almasmoum, Hussain Almaimani, Riyad A. El-Boshy, Mohamed Aslam, Akhmed Idris, Shakir Ghaith, Mazen M. El-Readi, Mahmoud Z. Ahmad, Jawwad Farrash, Wesam F. Mujalli, Abdulrahman Eid, Safaa Y. Elzubier, Mohamed E. Refaat, Bassem |
| description | Cadmium (Cd) is a major environmental pollutant and chronic toxicity could induce nephropathy by increasing renal oxidative stress and inflammation. Although vitamin D (VD) and calcium (Ca) prophylactic treatments attenuated Cd-induced cell injury, none of the prior studies measure their renoprotective effects against pre-established Cd-nephropathy.
To measure the alleviating effects of VD and/or Ca single and dual therapies against pre-established nephrotoxicity induced by chronic Cd toxicity prior to treatment initiation.
Forty male adult rats were allocated into: negative controls (NC), positive controls (PC), Ca, VD and VC groups. The study lasted for eight weeks and all animals, except the NC, received CdCl2 in drinking water (44 mg/L) throughout the study. Ca (100 mg/kg) and/or VD (350 IU/kg) were given (five times/week) during the last four weeks to the designated groups. Subsequently, the expression of transforming growth factor-β (TGF-β1), inducible nitric oxide synthase (iNOS), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), VD synthesising (Cyp27b1) and catabolizing (Cyp24a1) enzymes with VD receptor (VDR) and binding protein (VDBP) was measured in renal tissues. Similarly, renal expression of Ca voltage-dependent channels (CaV1.1/CaV3.1), store-operated channels (RyR1/ITPR1), and binding proteins (CAM/CAMKIIA/S100A1/S100B) were measured. Serum markers of renal function alongside several markers of oxidative stress (MDA/H2O2/GSH/GPx/CAT) and inflammation (IL-6/TNF-α/IL-10) together with renal cell apoptosis and expression of caspase-3 were also measured.
The PC group exhibited hypovitaminosis D, hypocalcaemia, hypercalciuria, proteinuria, reduced creatinine clearance, and increased renal apoptosis/necrosis with higher caspase-3 expression. Markers of renal tissue damage (TGF-β1/iNOS/NGAL/KIM-1), oxidative stress (MDA/H2O2), and inflammation (TNF-α/IL-1β/IL-6) increased, whilst the antioxidants (GSH/GPx/CAT) and IL-10 decreased, in the PC group. The PC renal tissues also showed abnormal expression of Cyp27b1, Cyp24a1, VDR, and VDBP, alongside Ca-membranous (CaV1.1/CaV3.1) and store-operated channels (RyR1/ITPR1) and cytosolic Ca-binding proteins (CAM/CAMKIIA/S100A1/S100B). Although VD was superior to Ca monotherapy, their combination revealed the best mitigation effects by attenuating serum and renal tissue Cd concentrations, inflammation and oxidative stress, alongside modulating the expression of VD/Ca-molec |
| doi_str_mv | 10.1016/j.jtemb.2023.127221 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2820028101</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0946672X23000974</els_id><sourcerecordid>2820028101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-127a6bec3663974bc52e3e0a9c3bb55daf35633bc552af06fea50f2e2b3f7a6c3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0EokPhCZCQl2wyOHZus2CBSksrVeoGEDvrxDmZeGTHwXZG5AH7XjgzpUtWts75_nP7CXmfs23O8urTYXuIaNstZ1xsc15znr8gm7ypm0zwkr8kG7Yrqqyq-a8L8iaEA2N5XTb8NbkQNS8KVlQb8vhTR7B6pF8pjB1VYJSeLVUuiwN6mBZqddR7iBjo5DHDEKE1Ogy4wp1d4RGnwbsJ4rDQdqEe97OBqMd9-o5gnosOzqJL-qgVtc6gmk2qurbVdvLuuCpgjDpzf3SXqCOekqeQHnsD1kJ0fqGgUjKNldRpcg_xLXnVgwn47um9JD9urr9f3Wb3D9_urr7cZ0qUu5ilI0HVohJVJXZ10aqSo0AGOyXatiw76EVZCZHiJYeeVT1CyXqOvBV9UipxST6e66Zxf8_pFtLqoNAYGNHNQfKGM8abZE9CxRlV3oXgsZeT1xb8InMmV__kQZ78k6t_8uxfUn14ajC3FrtnzT_DEvD5DGBa86jRy6A0jgo77VFF2Tn93wZ_ASPjs6M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2820028101</pqid></control><display><type>article</type><title>Vitamin D and calcium co-therapy mitigates pre-established cadmium nephropathy by regulating renal calcium homeostatic molecules and improving anti-oxidative and anti-inflammatory activities in rat</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Obaid, Ahmad A. ; Almasmoum, Hussain ; Almaimani, Riyad A. ; El-Boshy, Mohamed ; Aslam, Akhmed ; Idris, Shakir ; Ghaith, Mazen M. ; El-Readi, Mahmoud Z. ; Ahmad, Jawwad ; Farrash, Wesam F. ; Mujalli, Abdulrahman ; Eid, Safaa Y. ; Elzubier, Mohamed E. ; Refaat, Bassem</creator><creatorcontrib>Obaid, Ahmad A. ; Almasmoum, Hussain ; Almaimani, Riyad A. ; El-Boshy, Mohamed ; Aslam, Akhmed ; Idris, Shakir ; Ghaith, Mazen M. ; El-Readi, Mahmoud Z. ; Ahmad, Jawwad ; Farrash, Wesam F. ; Mujalli, Abdulrahman ; Eid, Safaa Y. ; Elzubier, Mohamed E. ; Refaat, Bassem</creatorcontrib><description>Cadmium (Cd) is a major environmental pollutant and chronic toxicity could induce nephropathy by increasing renal oxidative stress and inflammation. Although vitamin D (VD) and calcium (Ca) prophylactic treatments attenuated Cd-induced cell injury, none of the prior studies measure their renoprotective effects against pre-established Cd-nephropathy.
To measure the alleviating effects of VD and/or Ca single and dual therapies against pre-established nephrotoxicity induced by chronic Cd toxicity prior to treatment initiation.
Forty male adult rats were allocated into: negative controls (NC), positive controls (PC), Ca, VD and VC groups. The study lasted for eight weeks and all animals, except the NC, received CdCl2 in drinking water (44 mg/L) throughout the study. Ca (100 mg/kg) and/or VD (350 IU/kg) were given (five times/week) during the last four weeks to the designated groups. Subsequently, the expression of transforming growth factor-β (TGF-β1), inducible nitric oxide synthase (iNOS), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), VD synthesising (Cyp27b1) and catabolizing (Cyp24a1) enzymes with VD receptor (VDR) and binding protein (VDBP) was measured in renal tissues. Similarly, renal expression of Ca voltage-dependent channels (CaV1.1/CaV3.1), store-operated channels (RyR1/ITPR1), and binding proteins (CAM/CAMKIIA/S100A1/S100B) were measured. Serum markers of renal function alongside several markers of oxidative stress (MDA/H2O2/GSH/GPx/CAT) and inflammation (IL-6/TNF-α/IL-10) together with renal cell apoptosis and expression of caspase-3 were also measured.
The PC group exhibited hypovitaminosis D, hypocalcaemia, hypercalciuria, proteinuria, reduced creatinine clearance, and increased renal apoptosis/necrosis with higher caspase-3 expression. Markers of renal tissue damage (TGF-β1/iNOS/NGAL/KIM-1), oxidative stress (MDA/H2O2), and inflammation (TNF-α/IL-1β/IL-6) increased, whilst the antioxidants (GSH/GPx/CAT) and IL-10 decreased, in the PC group. The PC renal tissues also showed abnormal expression of Cyp27b1, Cyp24a1, VDR, and VDBP, alongside Ca-membranous (CaV1.1/CaV3.1) and store-operated channels (RyR1/ITPR1) and cytosolic Ca-binding proteins (CAM/CAMKIIA/S100A1/S100B). Although VD was superior to Ca monotherapy, their combination revealed the best mitigation effects by attenuating serum and renal tissue Cd concentrations, inflammation and oxidative stress, alongside modulating the expression of VD/Ca-molecules.
This study is the first to show improved alleviations against Cd-nephropathy by co-supplementing VD and Ca, possibly by better regulation of Ca-dependent anti-oxidative and anti-inflammatory actions.
[Display omitted]
•Cd induced abnormal expression of renal VD/Ca2+-regulatory molecules.•The dysregulation of VD/Ca2+-pathways could contribute to nephropathy.•VD and Ca2+ co-supplementation showed enhanced protection than monotherapies.•Co-therapy had better anti-oxidative, anti-inflammatory and calcaemic actions.</description><identifier>ISSN: 0946-672X</identifier><identifier>EISSN: 1878-3252</identifier><identifier>DOI: 10.1016/j.jtemb.2023.127221</identifier><identifier>PMID: 37244046</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Calmodulin ; Endoplasmic reticulum stress ; Inositol triphosphate receptor ; Ryanodine receptor ; Vitamin D receptor ; Voltage-dependent calcium channel</subject><ispartof>Journal of trace elements in medicine and biology, 2023-09, Vol.79, p.127221-127221, Article 127221</ispartof><rights>2023 Elsevier GmbH</rights><rights>Copyright © 2023 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-127a6bec3663974bc52e3e0a9c3bb55daf35633bc552af06fea50f2e2b3f7a6c3</citedby><cites>FETCH-LOGICAL-c359t-127a6bec3663974bc52e3e0a9c3bb55daf35633bc552af06fea50f2e2b3f7a6c3</cites><orcidid>0000-0003-4267-1016</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jtemb.2023.127221$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37244046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Obaid, Ahmad A.</creatorcontrib><creatorcontrib>Almasmoum, Hussain</creatorcontrib><creatorcontrib>Almaimani, Riyad A.</creatorcontrib><creatorcontrib>El-Boshy, Mohamed</creatorcontrib><creatorcontrib>Aslam, Akhmed</creatorcontrib><creatorcontrib>Idris, Shakir</creatorcontrib><creatorcontrib>Ghaith, Mazen M.</creatorcontrib><creatorcontrib>El-Readi, Mahmoud Z.</creatorcontrib><creatorcontrib>Ahmad, Jawwad</creatorcontrib><creatorcontrib>Farrash, Wesam F.</creatorcontrib><creatorcontrib>Mujalli, Abdulrahman</creatorcontrib><creatorcontrib>Eid, Safaa Y.</creatorcontrib><creatorcontrib>Elzubier, Mohamed E.</creatorcontrib><creatorcontrib>Refaat, Bassem</creatorcontrib><title>Vitamin D and calcium co-therapy mitigates pre-established cadmium nephropathy by regulating renal calcium homeostatic molecules and improving anti-oxidative and anti-inflammatory activities in rat</title><title>Journal of trace elements in medicine and biology</title><addtitle>J Trace Elem Med Biol</addtitle><description>Cadmium (Cd) is a major environmental pollutant and chronic toxicity could induce nephropathy by increasing renal oxidative stress and inflammation. Although vitamin D (VD) and calcium (Ca) prophylactic treatments attenuated Cd-induced cell injury, none of the prior studies measure their renoprotective effects against pre-established Cd-nephropathy.
To measure the alleviating effects of VD and/or Ca single and dual therapies against pre-established nephrotoxicity induced by chronic Cd toxicity prior to treatment initiation.
Forty male adult rats were allocated into: negative controls (NC), positive controls (PC), Ca, VD and VC groups. The study lasted for eight weeks and all animals, except the NC, received CdCl2 in drinking water (44 mg/L) throughout the study. Ca (100 mg/kg) and/or VD (350 IU/kg) were given (five times/week) during the last four weeks to the designated groups. Subsequently, the expression of transforming growth factor-β (TGF-β1), inducible nitric oxide synthase (iNOS), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), VD synthesising (Cyp27b1) and catabolizing (Cyp24a1) enzymes with VD receptor (VDR) and binding protein (VDBP) was measured in renal tissues. Similarly, renal expression of Ca voltage-dependent channels (CaV1.1/CaV3.1), store-operated channels (RyR1/ITPR1), and binding proteins (CAM/CAMKIIA/S100A1/S100B) were measured. Serum markers of renal function alongside several markers of oxidative stress (MDA/H2O2/GSH/GPx/CAT) and inflammation (IL-6/TNF-α/IL-10) together with renal cell apoptosis and expression of caspase-3 were also measured.
The PC group exhibited hypovitaminosis D, hypocalcaemia, hypercalciuria, proteinuria, reduced creatinine clearance, and increased renal apoptosis/necrosis with higher caspase-3 expression. Markers of renal tissue damage (TGF-β1/iNOS/NGAL/KIM-1), oxidative stress (MDA/H2O2), and inflammation (TNF-α/IL-1β/IL-6) increased, whilst the antioxidants (GSH/GPx/CAT) and IL-10 decreased, in the PC group. The PC renal tissues also showed abnormal expression of Cyp27b1, Cyp24a1, VDR, and VDBP, alongside Ca-membranous (CaV1.1/CaV3.1) and store-operated channels (RyR1/ITPR1) and cytosolic Ca-binding proteins (CAM/CAMKIIA/S100A1/S100B). Although VD was superior to Ca monotherapy, their combination revealed the best mitigation effects by attenuating serum and renal tissue Cd concentrations, inflammation and oxidative stress, alongside modulating the expression of VD/Ca-molecules.
This study is the first to show improved alleviations against Cd-nephropathy by co-supplementing VD and Ca, possibly by better regulation of Ca-dependent anti-oxidative and anti-inflammatory actions.
[Display omitted]
•Cd induced abnormal expression of renal VD/Ca2+-regulatory molecules.•The dysregulation of VD/Ca2+-pathways could contribute to nephropathy.•VD and Ca2+ co-supplementation showed enhanced protection than monotherapies.•Co-therapy had better anti-oxidative, anti-inflammatory and calcaemic actions.</description><subject>Calmodulin</subject><subject>Endoplasmic reticulum stress</subject><subject>Inositol triphosphate receptor</subject><subject>Ryanodine receptor</subject><subject>Vitamin D receptor</subject><subject>Voltage-dependent calcium channel</subject><issn>0946-672X</issn><issn>1878-3252</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1DAUhi0EokPhCZCQl2wyOHZus2CBSksrVeoGEDvrxDmZeGTHwXZG5AH7XjgzpUtWts75_nP7CXmfs23O8urTYXuIaNstZ1xsc15znr8gm7ypm0zwkr8kG7Yrqqyq-a8L8iaEA2N5XTb8NbkQNS8KVlQb8vhTR7B6pF8pjB1VYJSeLVUuiwN6mBZqddR7iBjo5DHDEKE1Ogy4wp1d4RGnwbsJ4rDQdqEe97OBqMd9-o5gnosOzqJL-qgVtc6gmk2qurbVdvLuuCpgjDpzf3SXqCOekqeQHnsD1kJ0fqGgUjKNldRpcg_xLXnVgwn47um9JD9urr9f3Wb3D9_urr7cZ0qUu5ilI0HVohJVJXZ10aqSo0AGOyXatiw76EVZCZHiJYeeVT1CyXqOvBV9UipxST6e66Zxf8_pFtLqoNAYGNHNQfKGM8abZE9CxRlV3oXgsZeT1xb8InMmV__kQZ78k6t_8uxfUn14ajC3FrtnzT_DEvD5DGBa86jRy6A0jgo77VFF2Tn93wZ_ASPjs6M</recordid><startdate>202309</startdate><enddate>202309</enddate><creator>Obaid, Ahmad A.</creator><creator>Almasmoum, Hussain</creator><creator>Almaimani, Riyad A.</creator><creator>El-Boshy, Mohamed</creator><creator>Aslam, Akhmed</creator><creator>Idris, Shakir</creator><creator>Ghaith, Mazen M.</creator><creator>El-Readi, Mahmoud Z.</creator><creator>Ahmad, Jawwad</creator><creator>Farrash, Wesam F.</creator><creator>Mujalli, Abdulrahman</creator><creator>Eid, Safaa Y.</creator><creator>Elzubier, Mohamed E.</creator><creator>Refaat, Bassem</creator><general>Elsevier GmbH</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4267-1016</orcidid></search><sort><creationdate>202309</creationdate><title>Vitamin D and calcium co-therapy mitigates pre-established cadmium nephropathy by regulating renal calcium homeostatic molecules and improving anti-oxidative and anti-inflammatory activities in rat</title><author>Obaid, Ahmad A. ; Almasmoum, Hussain ; Almaimani, Riyad A. ; El-Boshy, Mohamed ; Aslam, Akhmed ; Idris, Shakir ; Ghaith, Mazen M. ; El-Readi, Mahmoud Z. ; Ahmad, Jawwad ; Farrash, Wesam F. ; Mujalli, Abdulrahman ; Eid, Safaa Y. ; Elzubier, Mohamed E. ; Refaat, Bassem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-127a6bec3663974bc52e3e0a9c3bb55daf35633bc552af06fea50f2e2b3f7a6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Calmodulin</topic><topic>Endoplasmic reticulum stress</topic><topic>Inositol triphosphate receptor</topic><topic>Ryanodine receptor</topic><topic>Vitamin D receptor</topic><topic>Voltage-dependent calcium channel</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Obaid, Ahmad A.</creatorcontrib><creatorcontrib>Almasmoum, Hussain</creatorcontrib><creatorcontrib>Almaimani, Riyad A.</creatorcontrib><creatorcontrib>El-Boshy, Mohamed</creatorcontrib><creatorcontrib>Aslam, Akhmed</creatorcontrib><creatorcontrib>Idris, Shakir</creatorcontrib><creatorcontrib>Ghaith, Mazen M.</creatorcontrib><creatorcontrib>El-Readi, Mahmoud Z.</creatorcontrib><creatorcontrib>Ahmad, Jawwad</creatorcontrib><creatorcontrib>Farrash, Wesam F.</creatorcontrib><creatorcontrib>Mujalli, Abdulrahman</creatorcontrib><creatorcontrib>Eid, Safaa Y.</creatorcontrib><creatorcontrib>Elzubier, Mohamed E.</creatorcontrib><creatorcontrib>Refaat, Bassem</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of trace elements in medicine and biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Obaid, Ahmad A.</au><au>Almasmoum, Hussain</au><au>Almaimani, Riyad A.</au><au>El-Boshy, Mohamed</au><au>Aslam, Akhmed</au><au>Idris, Shakir</au><au>Ghaith, Mazen M.</au><au>El-Readi, Mahmoud Z.</au><au>Ahmad, Jawwad</au><au>Farrash, Wesam F.</au><au>Mujalli, Abdulrahman</au><au>Eid, Safaa Y.</au><au>Elzubier, Mohamed E.</au><au>Refaat, Bassem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vitamin D and calcium co-therapy mitigates pre-established cadmium nephropathy by regulating renal calcium homeostatic molecules and improving anti-oxidative and anti-inflammatory activities in rat</atitle><jtitle>Journal of trace elements in medicine and biology</jtitle><addtitle>J Trace Elem Med Biol</addtitle><date>2023-09</date><risdate>2023</risdate><volume>79</volume><spage>127221</spage><epage>127221</epage><pages>127221-127221</pages><artnum>127221</artnum><issn>0946-672X</issn><eissn>1878-3252</eissn><abstract>Cadmium (Cd) is a major environmental pollutant and chronic toxicity could induce nephropathy by increasing renal oxidative stress and inflammation. Although vitamin D (VD) and calcium (Ca) prophylactic treatments attenuated Cd-induced cell injury, none of the prior studies measure their renoprotective effects against pre-established Cd-nephropathy.
To measure the alleviating effects of VD and/or Ca single and dual therapies against pre-established nephrotoxicity induced by chronic Cd toxicity prior to treatment initiation.
Forty male adult rats were allocated into: negative controls (NC), positive controls (PC), Ca, VD and VC groups. The study lasted for eight weeks and all animals, except the NC, received CdCl2 in drinking water (44 mg/L) throughout the study. Ca (100 mg/kg) and/or VD (350 IU/kg) were given (five times/week) during the last four weeks to the designated groups. Subsequently, the expression of transforming growth factor-β (TGF-β1), inducible nitric oxide synthase (iNOS), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), VD synthesising (Cyp27b1) and catabolizing (Cyp24a1) enzymes with VD receptor (VDR) and binding protein (VDBP) was measured in renal tissues. Similarly, renal expression of Ca voltage-dependent channels (CaV1.1/CaV3.1), store-operated channels (RyR1/ITPR1), and binding proteins (CAM/CAMKIIA/S100A1/S100B) were measured. Serum markers of renal function alongside several markers of oxidative stress (MDA/H2O2/GSH/GPx/CAT) and inflammation (IL-6/TNF-α/IL-10) together with renal cell apoptosis and expression of caspase-3 were also measured.
The PC group exhibited hypovitaminosis D, hypocalcaemia, hypercalciuria, proteinuria, reduced creatinine clearance, and increased renal apoptosis/necrosis with higher caspase-3 expression. Markers of renal tissue damage (TGF-β1/iNOS/NGAL/KIM-1), oxidative stress (MDA/H2O2), and inflammation (TNF-α/IL-1β/IL-6) increased, whilst the antioxidants (GSH/GPx/CAT) and IL-10 decreased, in the PC group. The PC renal tissues also showed abnormal expression of Cyp27b1, Cyp24a1, VDR, and VDBP, alongside Ca-membranous (CaV1.1/CaV3.1) and store-operated channels (RyR1/ITPR1) and cytosolic Ca-binding proteins (CAM/CAMKIIA/S100A1/S100B). Although VD was superior to Ca monotherapy, their combination revealed the best mitigation effects by attenuating serum and renal tissue Cd concentrations, inflammation and oxidative stress, alongside modulating the expression of VD/Ca-molecules.
This study is the first to show improved alleviations against Cd-nephropathy by co-supplementing VD and Ca, possibly by better regulation of Ca-dependent anti-oxidative and anti-inflammatory actions.
[Display omitted]
•Cd induced abnormal expression of renal VD/Ca2+-regulatory molecules.•The dysregulation of VD/Ca2+-pathways could contribute to nephropathy.•VD and Ca2+ co-supplementation showed enhanced protection than monotherapies.•Co-therapy had better anti-oxidative, anti-inflammatory and calcaemic actions.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>37244046</pmid><doi>10.1016/j.jtemb.2023.127221</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4267-1016</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0946-672X |
| ispartof | Journal of trace elements in medicine and biology, 2023-09, Vol.79, p.127221-127221, Article 127221 |
| issn | 0946-672X 1878-3252 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2820028101 |
| source | Elsevier ScienceDirect Journals Complete |
| subjects | Calmodulin Endoplasmic reticulum stress Inositol triphosphate receptor Ryanodine receptor Vitamin D receptor Voltage-dependent calcium channel |
| title | Vitamin D and calcium co-therapy mitigates pre-established cadmium nephropathy by regulating renal calcium homeostatic molecules and improving anti-oxidative and anti-inflammatory activities in rat |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T08%3A22%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vitamin%20D%20and%20calcium%20co-therapy%20mitigates%20pre-established%20cadmium%20nephropathy%20by%20regulating%20renal%20calcium%20homeostatic%20molecules%20and%20improving%20anti-oxidative%20and%20anti-inflammatory%20activities%20in%20rat&rft.jtitle=Journal%20of%20trace%20elements%20in%20medicine%20and%20biology&rft.au=Obaid,%20Ahmad%20A.&rft.date=2023-09&rft.volume=79&rft.spage=127221&rft.epage=127221&rft.pages=127221-127221&rft.artnum=127221&rft.issn=0946-672X&rft.eissn=1878-3252&rft_id=info:doi/10.1016/j.jtemb.2023.127221&rft_dat=%3Cproquest_cross%3E2820028101%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2820028101&rft_id=info:pmid/37244046&rft_els_id=S0946672X23000974&rfr_iscdi=true |